ExufiberAG+02 for Pressure Sore

N/A

Waitlist Available

Research Sponsored by Molnlycke Health Care AB

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 28 days

Awards & highlights

Study Summary

This trial is testing a new silver dressing for wounds. The dressing is safe and effective for use on chronic wounds.

Eligible Conditions

Venous Leg Ulcer
Pressure Sore
Foot Ulcer

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 28 days

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~28 days

This trial's timeline: 3 weeks for screening, Varies for treatment, and 28 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

evaluate the safety and performance of Exufiber Ag+ in medium to high exuding chronic wounds

Trial Design

1Treatment groups

Experimental Treatment

Group I: ExufiberAG+02Experimental Treatment1 Intervention

using ExufiberAG as the primary dressing on medium to high exuding chronic wounds.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Molnlycke Health Care ABLead Sponsor

54 Previous Clinical Trials

7,779 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there an ongoing recruitment process for this research experiment?

"Affirmative. Clinicaltrials.gov showcases that this medical research, which was first publicized on January 1st 2022, is currently in need of participants. In total 102 individuals are sought from 2 centers for the study."

Answered by AI

How many participants has this clinical trial recruited thus far?

"Affirmative. The clinical trial page hosted on clinicaltrials.gov shows that the research initiative, which was initially posted January 1st 2022 and lastly edited August 8th 2022, is actively seeking participants. Specifically, 102 candidates need to be enrolled from 2 sites for this study."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

An Open, Non-comparative, Multicenter Investigation to Evaluate the Safety and Performance of Exufiber Ag+, a Gelling Fiber Silver Dressing, When Used in Medium to High Exuding Chronic Wounds

2022. "An Open, Non-comparative, Multicenter Investigation to Evaluate the Safety and Performance of Exufiber Ag+, a Gelling Fiber Silver Dressing, When Used in Medium to High Exuding Chronic Wounds". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05494450.